Reducing the risk of autoimmune disease
AssigneeMead Johnson Nutrition (Asia Pacific) Pte. Ltd.
InventorsDirk Hondmann, Eric A.F. van Tol, Gabriele Gross, Marieke H. Schoemaker, Teartse Tim Lambers
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a method for reducing the risk of autoimmune disease by administering a composition comprising peptides selected from a casein hydrolysate. Such a composition, may reduce the symptoms of autoimmune disease and may be a treatment for autoimmune disease, especially type 1 diabetes. Preferably, the hydrolysate consists of peptides with a molecular weight of more than 500 Da.
Claims13
A method for reducing the risk of autoimmune disease, treating autoimmune disease, and/or reducing the symptoms of autoimmune disease in a subject by administering a composition comprising a casein hydrolysate to the subject, wherein the hydrolysate consists of peptides with a molecular weight of more than 500 Da.
Dependencies are inferred from the claim text.